Company intelligence / Profile preview

Management Lanmeng Investment

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Lanmeng Capital, also known as Shanghai Lanmeng Investment Management, is a prominent Chinese venture capital firm specializing in the healthcare and life sciences sectors. The firm focuses on early-to-growth stage investments in biotechnology, medical devices, and digital health companies within the Chinese market. Lanmeng Capital is known for its strategic investments in high-growth biopharmaceutical companies, providing not only capital but also industry expertise and networking opportunities to its portfolio companies. The firm plays a significant role in fostering innovation within the Chinese healthcare ecosystem by supporting startups that address unmet medical needs.

Industry: Investors

Beyond the preview

Go deeper on Management Lanmeng Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Management Lanmeng Investment.

Explore the full profile